<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    <div class="gem-c-title govuk-!-margin-top-8 govuk-!-margin-bottom-8">
    <span class="govuk-caption-xl gem-c-title__context">
      Press release
    </span>
  <h1 class="gem-c-title__text gem-c-title__text--long">
    Sleep disorder drug modafinil linked to increased risk of birth defects and also to reduced effectiveness of contraception
  </h1>
</div>
  </div>
  
  <div class="govuk-grid-column-two-thirds">
    
  <p class="gem-c-lead-paragraph">Women using modafinil are being warned of an increased risk of birth defects associated with modafinil use during pregnancy. </p>

  </div>
</div>

<div class="govuk-grid-row">
  <div class="metadata-logo-wrapper">
    <div class="govuk-grid-column-two-thirds metadata-column">
        <div class="app-c-publisher-metadata" lang="en">
    <div class="app-c-published-dates " lang="en">
    Published 16 November 2020
</div>

      <div class="app-c-publisher-metadata__other">
        <dl data-module="track-click">
            <dt class="app-c-publisher-metadata__term">
              From:
            </dt>
            <dd class="app-c-publisher-metadata__definition" data-module="gem-toggle">
                <span class="app-c-publisher-metadata__definition-sentence">
                  <a class="govuk-link" href="/government/organisations/medicines-and-healthcare-products-regulatory-agency">Medicines and Healthcare products Regulatory Agency</a> and <a class="govuk-link" href="/government/people/nadine-dorries">Nadine Dorries MP</a>
                </span>
            </dd>
        </dl>
      </div>
  </div>

    </div>
    <div class="govuk-grid-column-one-third">
    </div>
  </div>
</div>




<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds content-bottom-margin">
    <div class="responsive-bottom-margin">
      <figure class="app-c-figure" lang="en">
  <img class="app-c-figure__image" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/image_data/file/108653/s300_MHRA-govUK.gif" alt="MHRA logo"></img>
    <figcaption class="app-c-figure__figcaption">

    </figcaption>
</figure>

      
<div class="gem-c-govspeak govuk-govspeak direction-ltr" data-module="govspeak">
    
        <div class="govspeak">
<ul>
  <li>Modafinil (Provigil) causes an approximate 15% likelihood of birth defects when taken during pregnancy; this compares with 3% in the general population</li>
  <li>Evidence that modafinil also reduces effectiveness of oral contraception</li>
  <li>Healthcare professionals treating narcolepsy with modafinil are also being reminded of the need to ensure patients are taking effective measures to prevent pregnancy</li>
</ul>

<p>The warning comes from the Medicines and Healthcare products Regulatory Agency (MHRA) following careful <a href="https://www.gov.uk/drug-safety-update/modafinil-provigil-increased-risk-of-congenital-malformations-if-used-during-pregnancy" class="govuk-link">ongoing review of the risks</a>. The drug may also reduce the effectiveness of oral contraception. Women taking modafinil should take effective measures to prevent pregnancy and discuss their contraception options with their healthcare professional.</p>

<p>This new advice is based on reports from a US study (of 61 babies exposed to modafinil in pregnancy) which showed that use of modafinil during pregnancy by women with narcolepsy possibly caused congenital malformations (including congenital heart defects, hypospadias, and orofacial clefts) in affected children.</p>

<p>Modafinil is a prescription-only medicine that is licensed only for the treatment of narcolepsy, a chronic disorder associated with sudden sleep that can cause serious disturbances to a patient’s quality of life.  As with any drug, there can be side effects associated with its use, including for modafinil psychiatric disorders (depression, suicidal behaviours, and psychosis) serious skin reactions and cardiovascular disorders.</p>

<p><strong>Dr Sarah Branch, director of MHRA’s Vigilance and Risk Management of Medicines division said</strong>:</p>

<blockquote>
  <p class="last-child">It is important that women are aware of the increased risk of congenital malformations associated with taking modafinil during pregnancy.</p>
</blockquote>

<blockquote>
  <p class="last-child">Modafinil can reduce the effectiveness of many hormonal contraceptives, including the pill. Women should discuss their options with their healthcare professional and continue to use their contraceptive for 2 months after stopping modafinil.</p>
</blockquote>

<blockquote>
  <p class="last-child">If you have any concerns, you should speak to your healthcare professional.</p>
</blockquote>

<blockquote>
  <p class="last-child">Patient safety is our highest priority. We strongly encourage anyone to report any side effects, from this or any medicine, to our <a rel="external" href="https://yellowcard.mhra.gov.uk/" class="govuk-link">Yellow Card scheme</a>.</p>
</blockquote>

<p><strong>Minister for Women’s Health and Patient Safety Nadine Dorries said</strong>:</p>

<blockquote>
  <p class="last-child">It is crucial that everybody is aware of the potential side effects of any medication they are taking.</p>
</blockquote>

<blockquote>
  <p class="last-child">Modafinil should only be taken when prescribed by a healthcare professional to treat narcolepsy and it is important all women taking it are aware of the potential risks including reducing the effectiveness of oral contraceptives and possible birth defects.</p>
</blockquote>

<blockquote>
  <p class="last-child">I urge all those taking modafinil to educate themselves on the side effects and potential risks, and to contact a healthcare professional if they are concerned.</p>
</blockquote>

<div class="contact postal-address" id="contact_2345">
  <div class="content">
    <h3>Media enquiries</h3>

    <div class="vcard contact-inner">
        <p class="adr">
<span class="fn">News centre</span><br></br>
<span class="street-address">MHRA
<br></br>
10 South Colonnade</span><br></br>
<span class="locality">London</span><br></br>
<span class="postal-code">E14 4PU</span>
</p>


        <div class="email-url-number">
            <p class="email">
              <span class="type">Email</span>
              <a class="govuk-link" href="mailto:newscentre@mhra.gov.uk">newscentre@mhra.gov.uk</a>
            </p>
            <p class="tel">
              <span class="type">During office hours:</span>
              020 3080 7651 (08:30 - 17:00)
            </p>
            <p class="tel">
              <span class="type">Out of office hours:</span>
              07770 446 189 (17:00 - 08:30)
            </p>
        </div>

        <p class="comments">
          Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at <a href="https://www.twitter.com/mhragovuk" class="govuk-link">https://www.twitter.com/mhragovuk</a>
        </p>

    </div>
  </div>
</div>
</div>

</div>
    </div>

    <div class="dont-print responsive-bottom-margin">
        <div class="gem-c-share-links " data-module="track-click">
      <h2 class="gem-c-share-links__title">Share this page</h2>

    <ul class="gem-c-share-links__list">
        <li class="gem-c-share-links__list-item">
          <a target="_blank" rel="noopener noreferrer external" data-track-category="social media" data-track-action="facebook" data-track-options="{"socialAction":"share","socialNetwork":"facebook","socialTarget":"https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2Fsleep-disorder-drug-modafinil-linked-to-increased-risk-of-birth-defects-and-also-to-reduced-effectiveness-of-contraception"}" class="gem-c-share-links__link " href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2Fsleep-disorder-drug-modafinil-linked-to-increased-risk-of-birth-defects-and-also-to-reduced-effectiveness-of-contraception">
            <span class="gem-c-share-links__link-icon">
                <svg xmlns="http://www.w3.org/2000/svg" width="32" height="32" aria-hidden="true">
                  <path fill="currentColor" d="M31.006 0H.993A.997.997 0 0 0 0 .993v30.014c0 .55.452.993.993.993h30.013a.998.998 0 0 0 .994-.993V.993A.999.999 0 0 0 31.006 0z"></path>
                  <path fill="#FFF" d="M17.892 10.751h1.787V8.009L17.216 8c-2.73 0-3.352 2.045-3.352 3.353v1.828h-1.581v2.824h1.581V24h3.322v-7.995h2.242l.291-2.824h-2.533V11.52c.001-.623.415-.769.706-.769z"></path>
                </svg>

            </span>          <span class="govuk-visually-hidden">
              Share on
          </span>
          <span class="visually-hidden">Share on </span>Facebook
</a>
        </li>
        <li class="gem-c-share-links__list-item">
          <a target="_blank" rel="noopener noreferrer external" data-track-category="social media" data-track-action="twitter" data-track-options="{"socialAction":"share","socialNetwork":"twitter","socialTarget":"https://twitter.com/share?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2Fsleep-disorder-drug-modafinil-linked-to-increased-risk-of-birth-defects-and-also-to-reduced-effectiveness-of-contraception\u0026text=Sleep%20disorder%20drug%20modafinil%20linked%20to%20increased%20risk%20of%20birth%20defects%20and%20also%20to%20reduced%20effectiveness%20of%20contraception"}" class="gem-c-share-links__link " href="https://twitter.com/share?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2Fsleep-disorder-drug-modafinil-linked-to-increased-risk-of-birth-defects-and-also-to-reduced-effectiveness-of-contraception&text=Sleep%20disorder%20drug%20modafinil%20linked%20to%20increased%20risk%20of%20birth%20defects%20and%20also%20to%20reduced%20effectiveness%20of%20contraception">
            <span class="gem-c-share-links__link-icon">
                <svg xmlns="http://www.w3.org/2000/svg" width="32" height="32" aria-hidden="true">
                  <path fill="currentColor" d="M31.007 0H.993A.999.999 0 0 0 0 .993v30.014c0 .55.452.993.993.993h30.014a.997.997 0 0 0 .993-.993V.993A.998.998 0 0 0 31.007 0z"></path>
                  <path fill="#FFF" d="M8 21.027a9.286 9.286 0 0 0 5.032 1.475c6.038 0 9.34-5.002 9.34-9.339 0-.143-.004-.284-.012-.425a6.619 6.619 0 0 0 1.639-1.699c-.6.265-1.234.439-1.885.516a3.287 3.287 0 0 0 1.443-1.816 6.571 6.571 0 0 1-2.086.797 3.28 3.28 0 0 0-5.592 2.993 9.311 9.311 0 0 1-6.766-3.43 3.294 3.294 0 0 0-.443 1.651 3.28 3.28 0 0 0 1.46 2.732 3.278 3.278 0 0 1-1.488-.411v.041a3.288 3.288 0 0 0 2.633 3.22 3.28 3.28 0 0 1-1.481.055 3.285 3.285 0 0 0 3.065 2.281 6.59 6.59 0 0 1-4.076 1.404A6.76 6.76 0 0 1 8 21.027z"></path>
                </svg>

            </span>          <span class="govuk-visually-hidden">
              Share on
          </span>
          <span class="visually-hidden">Share on </span>Twitter
</a>
        </li>
    </ul>
</div>
    </div>

    <div class="app-c-published-dates " lang="en">
    Published 16 November 2020
</div>

  </div>

  
<div class="govuk-grid-column-one-third">
  
<div class="gem-c-contextual-sidebar">


    



</div>

</div>

</div>


  <div class="govuk-grid-row">
    <div class="govuk-grid-column-two-thirds">
        
  <div class="gem-c-contextual-footer">
    
  <div class="gem-c-related-navigation">





      <nav role="navigation" class="gem-c-related-navigation__nav-section" aria-labelledby="related-nav-topics-ede25082" data-module="gem-toggle">

    <h2 id="related-nav-topics-ede25082" class="gem-c-related-navigation__sub-heading gem-c-related-navigation__sub-heading--footer" data-track-count="footerRelatedItemSection">Explore the topic</h2>

  <ul class="gem-c-related-navigation__link-list" data-module="track-click">


        <li class="gem-c-related-navigation__link"><a class="gem-c-related-navigation__section-link gem-c-related-navigation__section-link--footer" data-track-category="relatedLinkClicked" data-track-action="1.1 Explore the topic" data-track-label="/topic/medicines-medical-devices-blood/vigilance-safety-alerts" data-track-options="{"dimension28":"1","dimension29":"Vigilance, safety alerts and guidance"}" href="/topic/medicines-medical-devices-blood/vigilance-safety-alerts">Vigilance, safety alerts and guidance</a></li>

  </ul>
</nav>

  </div>

  </div>


    </div>
  </div>